Skip to main content

Cocrystal Pharma, Inc.

COCP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001412486

In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Cocrystal Pharma, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of COCP: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3542+7
Shares9.74M20.0M+10.3M (+105.3%)
Value$13.5M$25.0M+$11.5M (+84.7%)

New holders (13)

Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to COCP in Q2 2021
InstitutionSharesValue% of portfolio
Sabby Management, LLC6,110,657$7.64M1.65%
Alyeska Investment Group, L.P.2,750,100$3.44M0.04%
Altium Capital Management LP776,000$970.0K0.22%
State Street Corp274,427$343.0K0.00%
Mariner, LLC200,055$250.0K0.00%
Citadel Advisors LLC109,736$137.0K0.00%
Charles Schwab Investment Management Inc39,234$50.0K0.00%
Western Wealth Management, LLC19,115$24.0K0.00%
Victory Capital Management Inc14,130$18.0K0.00%
Raymond James Financial Services Advisors, Inc.11,618$15.0K0.00%
Clean Yield Group5,000$6.00K0.00%
NVWM, LLC1,000$1.00K0.00%
Red Door Wealth Management, LLC330$00.00%

Sold out (6)

Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of COCP in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Gsa Capital Partners LLP43,225$60.0K
Qube Research & Technologies Ltd17,266$24.0K
North Star Investment Management Corp.2,250$3.00K
JPMorgan Chase & Co1,404$2.00K
Global Trust Asset Management, LLC1,001$1.00K
Sowell Financial Services LLC178$0